多囊性卵巢症候群治療藥物市場：按藥物類別、手術、分銷管道分類 - 全球預測 2023-2030

預計2023年全球多囊性卵巢症候群藥物市場規模將達3,25,021萬美元，複合年成長率為6.56%，2030年將達50,9587萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球多囊性卵巢症候群藥物市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球多囊性卵巢症候群治療藥物市場規模及預測為何？

2.在預測期內，COVID-19對全球多囊性卵巢症候群治療藥物市場的阻礙因素與影響有哪些？

3.在預測期內，全球多囊性卵巢症候群治療藥物市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球多囊性卵巢症候群治療藥物市場的競爭策略是什麼？

5.全球多囊性卵巢症候群藥物市場的技術趨勢和法律規範如何？

6.全球多囊性卵巢症候群治療藥物市場主要供應商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入多囊性卵巢症候群藥物全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 多囊性卵巢症候群（PCOS）的盛行率在世界各地不斷增加
    • 聯合用藥的採用增加
    • 加強組織配合措施，提升對 PCOS 的認知
  • 抑制因素
    • 缺乏治療多囊性卵巢症候群的已通過核准藥物
  • 機會
    • 正在進行的藥物開發研究和開發項目
    • 策略聯盟投資與產能擴張
  • 任務
    • 多囊性卵巢症候群藥物和治療方法的副作用
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 依藥物類別分類的多囊性卵巢症候群治療藥物市場

• 抗憂鬱症
• 抗肥胖
• 胰島素增敏劑
• 口服避孕藥

第7章 手術治療多囊性卵巢症候群藥物市場

• 腹腔鏡卵巢打孔術
• 卵巢楔形切除術

第8章 多囊性卵巢症候群治療藥物市場：按分銷管道

• 藥局
• 電子商務
• 不孕不育診所
• 醫院藥房

第9章 北美和南美多囊性卵巢症候群治療藥物市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太多囊卵巢症候群治療藥物市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲多囊性卵巢症候群治療藥物市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Polycystic Ovarian Syndrome Treatment Market is forecasted to grow significantly, with a projected USD 3,250.21 million in 2023 at a CAGR of 6.56% and expected to reach a staggering USD 5,095.87 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Polycystic Ovarian Syndrome Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Polycystic Ovarian Syndrome Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Class, market is studied across Anti-Depressants, Anti-Obesity, Insulin Sensitizing Agents, and Oral Contraceptives. The Oral Contraceptives is projected to witness significant market share during forecast period.

Based on Surgery, market is studied across Laparoscopic Ovarian Drilling and Ovarian Wedge Resection. The Ovarian Wedge Resection is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Drug Stores, E-Commerce, Fertility Clinics, and Hospital Pharmacies. The Drug Stores is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Polycystic Ovarian Syndrome Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Polycystic Ovarian Syndrome Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Polycystic Ovarian Syndrome Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Polycystic Ovarian Syndrome Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Polycystic Ovarian Syndrome Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Polycystic Ovarian Syndrome Treatment Market?

6. What is the market share of the leading vendors in the Global Polycystic Ovarian Syndrome Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Polycystic Ovarian Syndrome Treatment Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Polycystic Ovarian Syndrome Treatment Market, by Drug Class, 2022 vs 2030
• 4.3. Polycystic Ovarian Syndrome Treatment Market, by Surgery, 2022 vs 2030
• 4.4. Polycystic Ovarian Syndrome Treatment Market, by Distribution Channel, 2022 vs 2030
• 4.5. Polycystic Ovarian Syndrome Treatment Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of PCOS worldwide
    • 5.1.1.2. Increasing adoption of combination drugs
    • 5.1.1.3. Rising organizational efforts to create awareness regarding PCOS
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of approved drugs for PCOS
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development projects for drug development
    • 5.1.3.2. Strategic alliances and investment for capacity expansion
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects of PCOS drugs and treatment
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Polycystic Ovarian Syndrome Treatment Market, by Drug Class

• 6.1. Introduction
• 6.2. Anti-Depressants
• 6.3. Anti-Obesity
• 6.4. Insulin Sensitizing Agents
• 6.5. Oral Contraceptives

7. Polycystic Ovarian Syndrome Treatment Market, by Surgery

• 7.1. Introduction
• 7.2. Laparoscopic Ovarian Drilling
• 7.3. Ovarian Wedge Resection

8. Polycystic Ovarian Syndrome Treatment Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Drug Stores
• 8.3. E-Commerce
• 8.4. Fertility Clinics
• 8.5. Hospital Pharmacies

9. Americas Polycystic Ovarian Syndrome Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Polycystic Ovarian Syndrome Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, 2022 VS 2030
• FIGURE 3. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
• FIGURE 5. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2022 VS 2030 (%)
• FIGURE 6. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 7. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET DYNAMICS
• FIGURE 9. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 5. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY ANTI-DEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY ANTI-OBESITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY INSULIN SENSITIZING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 10. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY LAPAROSCOPIC OVARIAN DRILLING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY OVARIAN WEDGE RESECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 13. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG STORES , BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. CANADA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 28. CANADA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 29. CANADA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. CHINA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 45. CHINA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 46. CHINA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. INDIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 48. INDIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 49. INDIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. ITALY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 100. ITALY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 101. ITALY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. POLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 112. POLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 113. POLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. QATAR POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 115. QATAR POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 116. QATAR POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 145. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 146. POLYCYSTIC OVARIAN SYNDROME TREATMENT MARKET LICENSE & PRICING